铂类药物所致实体肿瘤患儿听力损伤

童楚鸿; 白杰; 刘晶; 赵文; 段超; 王希思; 金眉; 马晓莉; 苏雁; 刘海红

doi:10.3969/j.issn.1672-4933.2025.02.008

您当前的位置：

首页 >

文章列表页 >

铂类药物所致实体肿瘤患儿听力损伤

临床研究 | 更新时间：2026-07-11

- 铂类药物所致实体肿瘤患儿听力损伤
- Acoustic Injury Induced by Platinum in Children with Solid Tumors
- 中国听力语言康复科学杂志 2025年23卷第2期页码：140-144
- 作者机构：
  
  1.国家儿童医学中心/首都医科大学附属北京儿童医院肿瘤内科/儿童肿瘤中心/儿童肿瘤国家临床重点专科/首都医科大学基础-临床联合实验室（儿童肿瘤发病机制与创新药物研究实验室）/儿科重大疾病研究教育部重点实验室北京100045
  2.国家儿童医学中心/首都医科大学附属北京儿童医院耳鼻咽喉头颈外科/儿童耳鼻咽喉头颈外科疾病北京重点实验室北京 100045
- 作者简介：
  
  童楚鸿硕士住院医师；研究方向：儿童实体肿瘤
  苏雁，E-mail：suyanbch@sina.com
  刘海红，E-mail：liuhaihong@bch.com.cn
- 基金信息：
  
  国家自然科学基金“儿童神经母细胞瘤和肝母细胞瘤防控新策略研究”(82293660/82293665);国家重点研发计划资助“以数据驱动的儿童重大疾病临床用药规范和监管科学研究”(2023YFC2706100/2023YFC2706101)
- DOI：10.3969/j.issn.1672-4933.2025.02.008
  中图分类号： R764.5
- 收稿：2024-07-01，
  
  纸质出版：2025-03-15
- 稿件说明：
移动端阅览
童楚鸿,白杰,刘晶等.铂类药物所致实体肿瘤患儿听力损伤[J].中国听力语言康复科学杂志,2025,23(02):140-144.

TONG Chu-hong,BAI Jie,LIU Jing,et al.Acoustic Injury Induced by Platinum in Children with Solid Tumors[J].Chinese Scientific Journal of Hearing and Speech Rehabilitation,2025,23(02):140-144.
童楚鸿,白杰,刘晶等.铂类药物所致实体肿瘤患儿听力损伤[J].中国听力语言康复科学杂志,2025,23(02):140-144. DOI： 10.3969/j.issn.1672-4933.2025.02.008.

TONG Chu-hong,BAI Jie,LIU Jing,et al.Acoustic Injury Induced by Platinum in Children with Solid Tumors[J].Chinese Scientific Journal of Hearing and Speech Rehabilitation,2025,23(02):140-144. DOI： 10.3969/j.issn.1672-4933.2025.02.008.

摘要

目的

探究顺铂、卡铂与儿童实体肿瘤应用铂类药物与发生听力损伤的关系。

方法

选取2020年1月～2023年12月于首都医科大学附属北京儿童医院肿瘤内科应用卡铂和/或顺铂的实体肿瘤患儿进行听力监测，运用R语言进行统计学分析。

结果

共纳入622例患儿，其中72例（11.6%）发生听力损伤，出现听力损伤的中位时间为开始应用铂类药物的第12个月（1～124个月）。多因素分析显示，顺铂、顺铂合用卡铂、颅脑放疗、清髓剂量卡铂治疗、顺铂同时应用速尿与听力损伤相关（

0.05）。顺铂累积剂量与听力损伤之间呈非线性关系，当顺铂累积剂量大于680 mg/m

时，顺铂累积剂量每增加100 mg/m

，发生听力损伤的风险增加50%。卡铂与听力损伤关系不确定（

0.05）。

结论

顺铂与实体肿瘤患儿听力损伤风险相关，当顺铂累积剂量超过680 mg/m

时，患儿听力损伤的风险明显升高。

Abstract

Objective

To explore the relationship between cisplatin and carboplatin and hearing loss caused by platinum drugs in solid tumors in children.

Methods

From January 2020 to December 2023

children with solid tumors who used carboplatin and/or cisplatin in the Department of Medical Oncology

Beijing Children's Hospital

Capital Medical University

were enrolled for hearing monitoring and statistical analysis using R language.

Results

622 children were included in this study

of which 72 (11.6%) developed hearing loss

and the median time of hearing loss was 12 months (1-124 months) after the initiation of platinum drugs. Multivariate analysis showed that cisplatin

cisplatin combined with carboplatin

cranial radiotherapy

and cisplatin with furosemide were associated with hearing loss (

0.05). There was a nonlinear relationship between the cumulative cisplatin dose and hearing loss

with a 50% increase in the risk of hearing loss for every 100 mg/m

increase in cisplatin when the cumulative cisplatin dose was greater than 680 mg/m

. The relationship between carboplatin and hearing loss was uncertain (

0.05).

Conclusion

Cisplatin is associated with the risk of hearing loss in children with solid tumors. When the cumulative dose of cisplatin exceeds 680 mg/m2

the risk of hearing loss is significantly increased.

关键词

Keywords

references

Oun R , Moussa YE , Wheate NJ . The side effects of platinum-based chemotherapy drugs: a review for chemists [J ] . Dalton Trans , 2018 , 47 ( 19 ): 6645 - 6653 .

Strebel S , Baust K , Grabow D , et al . Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study [J ] . J Cancer Surviv , 2025 , 19 ( 1 ): 162 - 173 .

Li Y , Womer RB , Silber JH . Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose [J ] . Eur J Cancer , 2004 , 40 ( 16 ): 2445 - 2451 .

Neuwelt EA , Brummett RE , Doolittle ND , et al . First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate [J ] . J Pharmacol Exp Ther , 1998 , 286 ( 1 ): 77 - 84 .

Landier W , Knight K , Wong FL , et al . Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group [J ] . J Clin Oncol , 2014 , 32 ( 6 ): 527 - 534 .

Clemens E , De Vries AC , Pluijm SF , et al . Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study [J ] . Eur J Cancer , 2016 , 69 : 77 - 85 .

Moke DJ , Luo C , Millstein J , et al . Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study [J ] . Lancet Child Adolesc Health , 2021 , 5 ( 4 ): 274 - 283 .

Schell MJ , McHaney VA , Green AA , et al . Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation [J ] . J Clin Oncol , 1989 , 7 ( 6 ): 754 - 760 .

Keilty D , Khandwala M , Liu ZA , et al . Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children [J ] . J Clin Oncol , 2021 , 39 ( 34 ): 3813 - 3821 .

Huitema AD , Spaander M , Mathjt RA , et al . Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin [J ] . Ann Oncol , 2002 , 13 ( 3 ): 374 - 384 .

Friedman DL , Himelstein B , Shields CL , et al . Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma [J ] . J Clin Oncol , 2000 , 18 ( 1 ): 12 - 17 .

Martinez JA , Martin G , Sanz GF , et al . A phase II clinical trial of carboplatin infusion in high-risk acute nonlymphoblastic leukemia [J ] . J Clin Oncol , 1991 , 9 ( 1 ): 39 - 43 .

王生才 , 马晓莉 , 周怡 , 等 . 铂类化疗药对儿童实体肿瘤听觉影响的研究 [J ] . 中华耳科学杂志 , 2015 , 13 ( 3 ): 398 - 402 .

Brock PR , Knight KR , Freyer DR , et al . Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale [J ] . J Clin Oncol , 2012 , 30 ( 19 ): 2408 - 2417 .

Clemens E , Van den Heuvel-Eibrink MM , Mulder RL , et al . Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium [J ] . Lancet Oncol , 2019 , 20 ( 1 ): e29 - e41 .

Beyea JA , Lau C , Cooke B , et al . Long-Term Incidence and Predictors of Significant Hearing Loss Requiring Hearing Assistive Devices Among Childhood Cancer Survivors: A Population-Based Study [J ] . J Clin Oncol , 2020 , 38 ( 23 ): 2639 - 2646 .

Funt SA , Knezevic A , Wilson K , et al . Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors [J ] . Cancer , 2023 , 129 ( 24 ): 3952 - 3961 .

Frisina RD , Wheeler HE , Fossa SD , et al . Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer [J ] . J Clin Oncol , 2016 , 34 ( 23 ): 2712 - 2720 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

孤独症谱系障碍儿童自我意识的发展特征及其机制探讨

上海地区人工耳蜗植入儿童生活质量评估：基于Nijmegen量表的回顾性分析

《儿童助听器验配服务指南》团体标准解读

基于国际功能、残疾和健康分类理论的儿童言语心智发育筛查结果分析

语言康复需求儿童家庭康复干预综述